Investment-Grade Corporates: A Tale Of Two Markets
Investors should take a closer look at intermediate-maturity corporate bonds, as they present a more compelling opportunity than long-maturity bonds. The spread between intermediate and long bonds has compressed, reaching its narrowest level since the early days of the pandemic. Additionally, the yield advantage of long corporates over intermediate bonds is now close to zero. This means that investors with long-bond exposure are not being adequately compensated for the added risk. The tight spreads on long bonds are being driven by yield-focused investors like pension funds and insurance companies, who are buying long-dated securities to match their long-dated liabilities. As a result, long-dated bonds in the US, UK, and euro area all look relatively expensive. On the other hand, intermediate-term credit offers above-average spreads at present. In this challenging investment environment, it is important for investors to look beyond the surface and consider the nuances of different bond options.
Baron Real Estate Income Fund Q3 2023 Shareholder Letter
Baron Funds hosted a client educational webinar titled "Demystifying Real Estate: An Optimistic Perspective on the Prospects for Real Estate." In the webinar, Baron Funds provided an optimistic outlook on the prospects for real estate and discussed key investment themes. They highlighted that perceptions about real estate, such as a commercial real estate crisis on the horizon or 6-7% mortgage rates crippling the new home sales market, do not reflect reality. They identified several secular tailwinds that are driving demand in the real estate market, including budget-conscious home buyers, rising data consumption, aging baby boomers, and pharmaceutical R&D. Baron Funds also made a case for allocating capital to public real estate in an actively managed strategy, citing inflation protection, diversification, and strong historical returns as key benefits. They mentioned that many public real estate companies are currently undervalued and may benefit from the end of the Federal Reserve's tightening period. Baron Funds currently has investments in various REIT categories, focusing on secular growth REITs and short-lease duration REITs with pricing power. They believe the Fund's long-term return prospects are compelling.
Verizon: No Worries About Refinancing Rates Affecting Dividends
Verizon and T-Mobile are two of the largest network providers in the US, each offering unique perks and options to attract customers. While Verizon has the best 4G LTE network coverage and offers discounts on bundled packages, T-Mobile excels in 5G network coverage. T-Mobile has made significant investments in its 5G network, allowing it to offer a top-notch network and potentially raise prices. However, Verizon's decision to quietly roll out 5G while maintaining its dividend makes it an attractive option for income investors. Despite losing customers to competitors, Verizon's financials remain strong with steady revenue and cash flow growth. However, the company does have a significant debt pile, which could be concerning if interest rates rise and refinancing becomes expensive. A closer look at Verizon's debt schedule reveals that a refinancing rate increase could have a small impact on earnings and cash flow, and is unlikely to lead to a dividend cut. Overall, Verizon's high and reliable dividend, along with its attractive valuation, make it a better investment choice compared to T-Mobile.
America Movil: Strong LTV Trends Encouraging
America Movil (NYSE: AMX) has the potential for a rebound in upside, driven by increasing customer lifetime value (LTV) and a reduction in long-term debt. While Q3 2023 earnings showed a decline in total revenue and EBIT, this was mainly due to the appreciation of the Mexican peso. Adjusting for constant exchange rates, service revenue actually increased by 3.8%. Mexico remains the largest market for America Movil, with strong growth in LTV, rising average revenue per user (ARPU), and falling churn rates. Additionally, the company has reduced its long-term debt without impacting LTV. Despite a current quick ratio of 0.63, indicating a lower level of liquid assets to meet current liabilities, the reduction in long-term debt is likely to be tolerated by investors. The stock is potentially undervalued and has the capacity to rebound to previous levels of $22. However, macroeconomic factors and market sentiment towards emerging markets pose risks to the stock. Overall, America Movil is in a good position for long-term growth due to its improving financial metrics.
Kenvue: Consumer Health Giant's Journey From IPO To Legal Challenges And Beyond
Kenvue Inc., a subsidiary of Johnson & Johnson, is a prominent player in the consumer health industry. The company specializes in a wide range of products across various health and personal care segments, including pain relief, skincare, oral care, and baby care. Kenvue's extensive brand portfolio, which includes well-known names like Tylenol, Listerine, and Band-Aid, positions it as a major player in the consumer healthcare market.
In November 2021, Johnson & Johnson announced its strategic decision to separate its Consumer Health segment into a new publicly traded company, marking a significant milestone for Kenvue. The company then went public through an initial public offering (IPO) in May 2023, successfully selling 198,734,444 shares of common stock.
Despite facing competition from industry giants like Procter & Gamble and established consumer-health divisions of pharmaceutical companies, Kenvue maintains strong market leadership. The company's financial performance in the second quarter of 2023 showed a 5.4% increase in net sales, reflecting the appeal of its products in the consumer health market.
However, Kenvue does face potential risks, including a recent legal complaint alleging misleading disclosures in its IPO documents and potential legal challenges related to its Tylenol product. These challenges could impact the company's reputation and investor confidence.
Overall, while Kenvue has strong potential for growth in the consumer healthcare industry, it is important to closely monitor the company's ability to maintain its competitive edge and respond to market dynamics.